Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system. (12th December 2022)
- Record Type:
- Journal Article
- Title:
- Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system. (12th December 2022)
- Main Title:
- Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system
- Authors:
- Moungmaithong, Sakita
Leung, Bo Wah
Sahota, Daljit Singh
Wang, Chi Chui
Leung, Tak Yeung
Poon, Liona C. - Abstract:
- Abstract: Background: Recent evidence from a meta-analysis indicates that maternal prenatal exposure, single or repeated, to non-steroidal anti-inflammatory drugs (NSAIDs) or non-opioid painkillers, is associated with increased risk of cerebral palsy and cognitive-behavioral disorders in offspring. One potential route of action is interference with the neurulation process and hence early brain development. Objective: To examine the effect of prenatal exposure to common NSAIDs and non-opioid drugs on neurulation using an in vitro whole embryo culture system. Methods: Mouse embryos from in-bred Institute of Cancer Research albino strain mice were exteriorized on embryonic day 7.5 and cultured for 48 h in either 1 mL heat-inactivated rat serum + 0.1% dimethyl sulfoxide ("Control") or 1 mL of rat serum supplemented with six increasing concentrations of laboratory-grade aspirin, paracetamol, and ibuprofen ("Experimental"). After culture, embryo morphological and developmental parameters were documented using standardized scoring systems at each dosage concentration. The assessed concentration in rat serum culture ranged from 1.23 to 13.57 mg/mL for aspirin and 0.06–4.93 mg/mL for paracetamol and ibuprofen. The equivalent respective human dosages were 600–6600 mg and 30–2400 mg. Results: Between-group comparisons ("Control" vs "Experimental") and post-hoc pair-wise tests, adjusted for multiple comparisons, indicating no statistically significant effect on crown-rump length ( pAbstract: Background: Recent evidence from a meta-analysis indicates that maternal prenatal exposure, single or repeated, to non-steroidal anti-inflammatory drugs (NSAIDs) or non-opioid painkillers, is associated with increased risk of cerebral palsy and cognitive-behavioral disorders in offspring. One potential route of action is interference with the neurulation process and hence early brain development. Objective: To examine the effect of prenatal exposure to common NSAIDs and non-opioid drugs on neurulation using an in vitro whole embryo culture system. Methods: Mouse embryos from in-bred Institute of Cancer Research albino strain mice were exteriorized on embryonic day 7.5 and cultured for 48 h in either 1 mL heat-inactivated rat serum + 0.1% dimethyl sulfoxide ("Control") or 1 mL of rat serum supplemented with six increasing concentrations of laboratory-grade aspirin, paracetamol, and ibuprofen ("Experimental"). After culture, embryo morphological and developmental parameters were documented using standardized scoring systems at each dosage concentration. The assessed concentration in rat serum culture ranged from 1.23 to 13.57 mg/mL for aspirin and 0.06–4.93 mg/mL for paracetamol and ibuprofen. The equivalent respective human dosages were 600–6600 mg and 30–2400 mg. Results: Between-group comparisons ("Control" vs "Experimental") and post-hoc pair-wise tests, adjusted for multiple comparisons, indicating no statistically significant effect on crown-rump length ( p > .21), head length ( p > .28), somite number ( p > .25), incidence of absent hindlimb buds ( p > .18), yolk sac circulation score ( p > .07) and posterior neuropore closure ( p > .35) in the aspirin, paracetamol and ibuprofen experiments. All embryos had forelimb buds, closed anterior neuropores and none had neural tube defects. Conclusion: This study has demonstrated that there are no safety concerns regarding high-dose aspirin, ibuprofen, and paracetamol on mice's embryonic development. … (more)
- Is Part Of:
- Journal of maternal-fetal & neonatal medicine. Volume 35:Number 25(2022)
- Journal:
- Journal of maternal-fetal & neonatal medicine
- Issue:
- Volume 35:Number 25(2022)
- Issue Display:
- Volume 35, Issue 25 (2022)
- Year:
- 2022
- Volume:
- 35
- Issue:
- 25
- Issue Sort Value:
- 2022-0035-0025-0000
- Page Start:
- 8786
- Page End:
- 8793
- Publication Date:
- 2022-12-12
- Subjects:
- NSAIDS -- embryo -- malformations -- paracetamol -- aspirin
Obstetrics -- Periodicals
Perinatology -- Periodicals
Infants (Newborn) -- Diseases -- Periodicals
Neonatology -- Periodicals
618.2 - Journal URLs:
- http://informahealthcare.com/loi/jmf ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14767058.2021.2005020 ↗
- Languages:
- English
- ISSNs:
- 1476-7058
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5012.332000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24419.xml